iShares MSCI India ETF vs Lemonade Inc — how do they compare? iShares MSCI India ETF trades at $46.03 (market cap $5.73B), while Lemonade Inc trades at $46.5 (market cap $3.63B). The key difference: iShares MSCI India ETF is the larger of the two by market cap, and iShares MSCI India ETF is more actively traded (6,797,522 versus 1,544,794). Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI India ETF for 58 Days and Lemonade Inc for 27 Days on average.
| INDA | LMND | |
|---|---|---|
Market Cap | $5.73B | $3.63B |
Volume | 6,797,522 | 1,544,794 |
Sector | Broad Market / Factor | Financials |
52-Week High | $55.29 | $96.57 |
52-Week Low | $45.42 | $43.91 |
Typical Hold Time | 58 Days | 27 Days |
Enterprise Value | — | $3.49B |
Signals from Pluang's Aura AI — not financial advice
INDA trades at $45.98, down 0.3% with bearish technical signals showing 19 sell indicators versus 5 buy signals. The ETF faces headwinds from India's economic challenges including coal power shortages, monsoon concerns, and pharma sector export issues. Technical indicators show oversold conditions with RSI readings below 16, suggesting potential for near-term bounce despite the dominant bearish trend.
The outlook remains cautious as India's market composition with heavy banking sector exposure and external pressures from US tariff tensions create uncertainty. Key support at $45 provides critical technical level, while sector-specific challenges in technology and pharmaceuticals warrant careful monitoring of India's economic resilience.
LMND trades at $46.64, down 0.41% on the day, with a bearish technical signal despite recent earnings beats. Revenue growth remains strong at 32% year-over-year in Q2 2026, with improving loss ratios and gross profit up 76%. The company is expanding geographically and expects its first EBITDA-positive quarter in late 2026, supported by AI-driven efficiency gains.
While LMND shows promising growth and path to profitability, the stock faces headwinds from persistent net losses, high valuation multiples, and mixed analyst sentiment. The consensus price target of $67.00 suggests 44% upside potential, but investors must weigh growth prospects against ongoing cash burn and competitive pressures in the insurtech space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →